Weekly round-up #243
VALIDATE Annual Meeting - First Keynote Speakers Announced
We are pleased to announce our we have arranged two excellent speakers for the VALIDATE Annual Meeting! Prof Petro Terblanche and Dr Caryn Fenner from Afrigen will be speaking on behalf of the WHO mRNA Hub Technology Transfer Program.
This presentation will share the strategic intent, design, operation, scientific progress, technical and intellectual property challenges and partnerships of the mRNA technology development and transfer program created by WHO and partners. Its fundamental goal is to empower LMICs to respond to future pandemics through technology transfer creating sustainable capacity and capabilities to manufacture vaccines relevant for the burden of diseases in those regions. The Covid 19 pandemic has yet again surfaced the challenges of vaccine security for the Global South were insufficient skills and capacity resulted in dependence and vulnerability. Equitable access to vaccine technology platforms have become key to epidemic prevention and effective pandemic response in addition to contributing to socio-economic development. You can find out more details on the event page.
The Annual Meeting is currently full. But you can still add your name to the waiting list and register an interest in our VALIDATE Annual Meeting Online - www.validate-network.org/annual-meeting-2023
Happening 15:00 GMT today - VALIDATE Winter Seminar - A flexible and efficient platform to develop a nanovaccine against Burkholderia pseudomallei
There is still time to register for today's VALIDATE Seminar. Dr Alfredo Torres will discuss his Lab's work at UTMB which uses gold nanoparticles for the delivery of multicomponent antigens, identified by the bio-immunoinformatic analysis, that is able to induce vaccine-mediated immunity, promoting protection against melioidosis disease.
This seminar is open to all, so spread the word and register ASAP- www.validate-network.org/event/seminar-nanovaccine-burkholderia.
- BBSRC Vaccines Manufacturing Research Hubs - Apply for funding to establish a large-scale research hub to address challenges relating to vaccine delivery or manufacturing in low and middle-income countries - deadline: 15 December 2022
- MRC Developmental Pathway Funding Scheme - Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions - deadline 23 November 2022
- NIH Complement in Basic Immunology CIBI - Studies that accelerate our understanding of the roles of complement components and receptors in the initiation and quality of immune responses against infectious agents - deadline: 8 January 2023
You can find a list of all relevant external funding we've spotted for our members on our external funding page.
Training Opportunities and Events:
- Global Health Network Conference 2022, Cape Town, South Africa, 24 - 25 November 2022
- British Society for Immunology Congress 2022, Liverpool, United Kingdom, 5 December 2022
Find more training and events opportunities on our Training and Events pages.
- Pfizer Associate Scientist - Vaccine, Pfizer, Pearl River, New York, deadline 17 November 2022
- Postdoctoral Research Fellow, dinburgh - Bio-Quarter (Royal Infirmary), Midlothian, United Kingdom, deadline 21 November 2022
Other relevant career opportunities are on our jobs page.
- An ancestral mycobacterial effector promotes dissemination of infection, Saelens JW et al, in Cell
- Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosis, Masato Ogishi M et al, in
Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.
Highlights on Twitter this week:
Nature reported on the impact of financial distress in PhD students who often require part time jobs, reported onthe support needed by mid level researchers, how poorly the modern research community can treat its young scientists, and how many of them struggle with their workload. The BSi shared their review series on immunemetabolism, TB News Daily reported on Oxford's recent research on TB Correlates, and the Aurum Institutes CSO called for a full assessment of novel TB vaccines. IAVI shared a quote from David Lewinsohn on the importance of de-risking TB vaccines. The WHO released their report on global vaccine disparity, African researchers are calling for human trials for TB vaccines, and the South China Morning Post reported on a Melioidosis outbreak in Hong Kong.
Keep up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter.
Published: 16 November 2022
